Invitrogen™ DUS2L Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5104500

Catalog No. PIPA5104500

Description

Antibody detects endogenous levels of total DUS2L.

Dihydrouridine synthase catalyzes reduction of the 5,6-double bond of a uridine residue on the displacement loop of tRNA. The resultant modified base, 5,6-dihydrouridine, appears to increase the conformational flexibility and dynamic motion of tRNA (Kato et al., 2005 [PubMed 15994936]).

Specifications

• Antigen: DUS2L
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: DUS2
• Gene Alias: 2310016K04Rik; Dihydrouridine synthase 2; dihydrouridine synthase 2-like, SMM1 homolog; Dus2; Dus2l; hDUS2; RGD1305612; SMM1; SMM1 homolog; tRNA-dihydrouridine synthase 2-like; tRNA-dihydrouridine(20) synthase (NAD(P)(+)); tRNA-dihydrouridine(20) synthase [NAD(P)+]-like; Up-regulated in lung cancer protein 8; URLC8
• Host Species: Rabbit
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 291978, 54920, 66369
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: Q9D7B1, Q9NX74
• Gene Symbols: DUS2
• Immunogen: A synthesized peptide derived from human DUS2(Accession Q9NX74), corresponding to amino acid residues C430-V480.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse, Rat
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov